TY  - GEN
AU  - Di Costanzo,Francesco
AU  - Ravasio,Roberto
AU  - Sobrero,Alberto
AU  - Bertetto,Oscar
AU  - Vinante,Orazio
AU  - Luppi,Gabriele
AU  - Labianca,Roberto
AU  - Amadori,Dino
AU  - Barone,Carlo
AU  - Carlo Merlano,Marco
AU  - Longo,Flavia
AU  - Mansueto,Giovanni
AU  - Antonuzzo,Lorenzo
AU  - Gasperoni,Silvia
TI  - Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting
SN  - 1173-2563
PY  - 2009///0209
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Capecitabine
KW  - Chemotherapy, Adjuvant
KW  - economics
KW  - Clinical Trials, Phase III as Topic
KW  - Colonic Neoplasms
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Deoxycytidine
KW  - Female
KW  - Fluorouracil
KW  - Health Care Costs
KW  - Humans
KW  - Infusions, Parenteral
KW  - Italy
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - National Health Programs
KW  - Randomized Controlled Trials as Topic
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2165/00044011-200828100-00005
ER  -